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Background
In natural history of allergy, in some patients sensitized to
aeroallergens, appear allergy to novel allergens, and in
some cases this are food allergens. Subcutaneous immu-
notherapy (SIT) is the method of treatment patient with
pollen allergy, and one of the aim of this treatment is pro-
tection against development novel allergy, but sometimes
in clinical practice we observed hypersensitivity to new
allergens, especially to food allergens.
Aim
The aim of the study is assessment the prevalence of
hypersensitivity to novel food allergens in patients trea-
ted SIT.
Methods
We analysis case history 60 patients with SIT for aeroal-
lergens, in age 18 to 72 years (medium 55 years),
31 women and 29 man.
Result
Most patient were treated SIT due allergy to grass, and
in the next place to dust mites, trees and weeds. In
5 (8,3%) patients of treated SIT we develop hypersensi-
tivity to new food allergens. In 3 patients sensitized to
trees we recognized hypersensitivity to apple, nectarine,
peach, kiwi, carrot and hazelnut. In one patient sensi-
tized to grass we develop hypersensitivity to pistachio
nut, and in one patient sensitized to mugwort, hypersen-
sitivity to shrimp was recognized. Oral allergy syndrome
(OAS) was more common clinical manifestation - in
4 patients. One patient has rash on skin. All patient
were treated SIT during 4 or 5 years.
Conclusion
In our opinion in this cases of new hypersensitivity
probably were provoked by SIT and this method therapy
don’t protect all patients with pollen allergy against
development new allergy.
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